Clinical trials recruiting in Bethesda, Maryland
256
Recruiting trials
15
Conditions
Phase breakdown
Early Phase 1 1Phase 1 49Phase 2 66Phase 3 37Phase 4 1Not applicable 125
Conditions recruiting in Bethesda, Maryland
| Condition | Trials |
|---|---|
| Lung Cancer | 39 |
| Prostate Cancer | 28 |
| Breast Cancer | 27 |
| HIV | 27 |
| Colorectal Cancer | 20 |
| Epilepsy | 16 |
| Pancreatic Cancer | 16 |
| Melanoma | 15 |
| Multiple Sclerosis | 15 |
| Obesity | 15 |
| Sickle Cell Disease | 15 |
| Depression | 13 |
| Hypertension | 12 |
| Lupus | 9 |
| Non Small Cell Lung Cancer | 9 |
Recruiting trials in Bethesda, Maryland
- 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
- A Natural History Study of Bone and Mineral Disorders
- A Natural History Study of Metabolic Sizing in Health and Disease
- A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
- A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
- A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
- Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
- An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Blood Sampling for Research Related to Sickle Cell Disease
- CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Cancer in Inherited Bone Marrow Failure Syndromes
- Cardamom and Topical Roseomonas in Atopic Dermatitis
- Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
- Causes and Natural History of Dyslipidemias
- Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- Characterization and Treatment of Adolescent Depression
- Characterization of Diseases With Salivary Gland Involvement
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- Childhood-Onset Essential Hypertension Natural History Study
- Children s Growth and Behavior Study
- Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
- Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Collection of Blood From Patients With Cancer
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Collection of Blood From Patients With Prostate Cancer
- Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- Cooperative Assessment of Late Effects for SCD Curative Therapies
- DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Dabrafenib and/or Trametinib Rollover Study
- Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
- Deciphering the Genetic Architecture of Autoimmune Diseases
- Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
- Deep Brain Stimulation Surgery for Movement Disorders
- Deep Brain Stimulation Therapy in Movement Disorders
- Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
- Developing Brain, Impulsivity and Compulsivity
- Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- Diabetes and Heart Disease Risk in Blacks
- Diagnosing and Treating Low Blood Sugar Levels
- Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
- Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- Dinner Time for Obesity and Prediabetes
- Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
- Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- Effects of Treatments on Atopic Dermatitis
- Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
- Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
- Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Showing 100 of 256 recruiting trials.
Common questions
How many clinical trials are recruiting in Bethesda, Maryland?
256 recruiting trials have at least one study site in Bethesda, Maryland.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.